ketoconazole , an orally active imidazole derivative , has been approved by the food and drug administration for the treatment of candidiasis , chronic mucocutaneous candidiasis , oral thrush , candiduria , coccidioidomycosis , histoplasmosis , chromomycosis , and paracoccidioidomycosis .
C0022625
ketoconazole
C0009186
coccidioidomycosis